Design Therapeutics (DSGN) Interest Income - Net (2024 - 2026)

Design Therapeutics (DSGN) has 3 years of Interest Income - Net data on file, last reported at -$1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Income - Net fell 893.83% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$1.5 million (down 159.17% YoY), and the FY2025 full-year result was -$53.7 billion, down 173.54% from the prior year.
• Interest Income - Net eased to -$1.3 million in Q1 2026, from -$14000.0 in the prior quarter.
• In the past five years, Interest Income - Net ranged from a high of $1.1 million in Q1 2024 to a low of -$1.3 million in Q1 2026.
• A 3-year average of $237888.9 and a median of $162000.0 in 2025 frame the typical range for Interest Income - Net.
• Across the five-year window, Interest Income - Net tumbled 85.29% in 2025 and tumbled 893.83% in 2026, its largest moves.
• Tracing DSGN's Interest Income - Net over 3 years: stood at $406000.0 in 2024, then plunged by 103.45% to -$14000.0 in 2025, then tumbled by 9085.71% to -$1.3 million in 2026.
• Business Quant data shows DSGN's Interest Income - Net at -$1.3 million in Q1 2026, -$14000.0 in Q4 2025, and $46000.0 in Q3 2025.